Relapsed plasmablastic lymphoma in a HIV‐negative patient: Pushing the envelope

Relapsed plasmablastic lymphoma in a HIV‐negative patient: Pushing the envelope

Abstract This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV‐negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.

Bibliographic Details
Main Authors: Manthan Kathrotiya, Vivek S Radhakrishnan, Saurabh J Bhave, Jeevan Kumar, Mita Roychowdhury, Indu Arun, Jayanta Das, Mammen Chandy, Reena Nair
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Clinical Case Reports
Subjects:
daratumumab
haploidentical transplantation
novel therapies
plasmablastic lymphoma
relapse
Online Access:https://doi.org/10.1002/ccr3.3673

Internet

https://doi.org/10.1002/ccr3.3673

Similar Items